RTOG Address
Search  
HomeMember InfoProtocolsResearcherMeetingsVisitorsFAQSite Map
RTOG  Data  Collection  and  Web  Registration  Information

RTOG Web-Based Registration and Data Collection Manual

FORMS AVAILABLE FOR ELECTRONIC DATA SUBMISSION (Centers enrolling patients through RTOG are required to submit RTOG study data via web-entry for the following studies/forms.)

  1. 0012 Phase II Rectal Follow-up (F1)
  2. 0113 Esophagus Follow-up (F1)
  3. 0114 Gastric Follow-up (F1)
  4. 0116 Phase II Cervix Follow-up (F1)
  5. 0126 Prostate Follow-up (F1)
  6. 0128 Cervix - Follow up (F1)
  7. 0129 Head and Neck Follow-up (F1)
  8. 0246 Esophagus Follow-up (F1)
  9. 0247 Rectal Follow-up (F1)
  10. 0319 Breast Follow-up (F1)
  11. 0320 Phase III Brain Follow-up (F1)
  12. 0415 Phase III Prostate Follow-up (F1), Initial Evaluation (I1), Radiotherapy Form (T1)
  13. 0417 Cervix Follow-up (F1), Initial Evaluation (I1)
  14. 0418 Phase II IMRT Radiotherapy Form(T1), Phase II Cx/Endo Follow-up (F1), Initial Evaluation (I1), Treatment Summary (TF)
  15. 0424 Phase II Brain Follow-up (F1)
  16. 0436 Phase III Esophagus Initial Evaluation (I1), Radiotherapy (T1), Post Treatment Response (F2)
  17. 0438 Phase I Liver Follow-up (F1)
  18. 0513 Phase I/II GBM Initial Evaluation(I1), Follow-up Form (F1)
  19. 0521 Radiotherapy Form (T1) ,Initial Follow-up (F0), Interim Follow Up (FS), Follow-up (F1), Initial Evaluation (I1)
  20. 0522 Advanced H & N Follow-up (F1), Radiotherapy Form (T1)
  21. 0525 Brain GBM all forms
  22. 0526 Phase II Prostate Brachy Initial Evaluation (I1), Followup Form (F1)
  23. 0529 Phase II Anal Canal Follow-up (F1), Initial Evaluation (I1), Post Treatment Response (F2), Radiotherapy (T1)
  24. 0534 Interim Follow-up Form (F0),Phase III Prostate Follow-up (F1), Initial Evaluation (I1), Radiotherapy Form (T1)
  25. 0611 GBM VEGF/MMP Follow-up (F1), Initial Evaluation (I1)
  26. 0614 Phase III Memantine/Placebo/WBRT Initial Evaluation (I1), Follow-up (F1), Treatment Summary (TF), Radiotherapy Form(T1)
  27. 0615 Phase II Nasopharyngeal Radiotherapy Form (T1)
  28. 0617 Phase III NSCLC Initial Evaluation (I1), Phase III NSCLC Followup Form (F1), Treatment Summary Form (TF), Radiotherapy Form (T1)
  29. 0618 Phase II SBRT Initial Evaluation (I1), Radiotherapy Form (T1)
  30. 0621 Phase II Prostate Initial Evaluation (I1), Phase II Prostate Radiotherapy (T1)
  31. 0622 Phase II Prostate Samarium Initial Evaluation (I1)
  32. 0623 Phase II SCLC Initial Evaluation (I1), Radiotherapy Form (T1)
  33. 0627 Phase II GBM Follow-up (F1), Initial Evaluation (I1)
  34. 0630 Phase III Sarcoma Initial Evaluation (I1), Radiotherapy(T1)
  35. 0822 Phase II Rectal Initial Evaluation Form(I1), Follow Up Form(F1), Surgery Form (S1), Post-op Treatment Summary Form (SF), Pre-op Treatment Summary Form (TF)
  36. 8531 Phase III Prostate Follow-up (F1)
  37. 9202 Phase III Prostate Follow-up (F1)
  38. 9406 Prostate Follow-up (F1)
  39. 9408 Prostate Follow-up (F1)
  40. 9413 Prostate Follow-up (F1)
  41. 9601 Prostate Follow-up (F1)
  42. 9704 Pancreas Follow-up (F1)
  43. 9804 DCIS Breast Follow-up (F1)
  44. 9811 Anal Canal Follow-up (F1)
  45. 9904 Follow-up Form (F1)
  46. 9910 Prostate Follow-up (F1)

WEB REGISTRATION & DATA SUBMISSION LINKS

PRACTICE
RTOG - Pilot (Study - 9998)

ACTIVE STUDIES
RTOG Protocols


SYSTEM REQUIREMENTS FOR WEB REGISTRATION

In the near future RTOG will embark on an initiative to activate Web registration for a number of its studies. In preparation for this event, we would like to provide some vital information which will assist you to determine if your site is appropriately equipped to participate in this new Web service.

In order to use the Web Registration module successfully, all participating sites must meet the minimum system requirements as indicated below:

  • Pentium III or greater processor with minimum 128 MB RAM.
  • Microsoft Windows 98, 2000 or XP.
  • Free Hard Drive Storage space 100 MB.
  • Video card with 2 MB of RAM for minimum 16 bit (High Color) display
  • Internet Explorer version 6.0 or above installed.
  • Netscape Navigator 7.1.

Attached you will find two (2) documents that deal with the Internet Explorer and Netscape Navigator browser settings that have to be changed to meet our requirements.

Please take this opportunity to contact your local IT support staff to resolve any problems that may relate your ability to utilize this service.

  1. IE Browser Settings
  2. Navigator Browser Settings

If you would like to utilize Web Registration site to register a patient and have not been assigned a user name and password from RTOG Headquarters, please access the Password Authorization Form from the link provided. You must fill this form out completely and have it signed by the member institution Principal Investigator. All forms should be faxed to RTOG Headquarters at (215) 928-0153.

  1. RTOG Password Authorization Form
OPEN STUDIES FOR WEB REGISTRATION
  1. 0123 - CAPTOPRIL FOR SMALL OR NONSMALL LUNG CANCER
  2. 0126 - PROSTATE:3D
  3. 0214 - LUNG: PCI FOR NON-SMALL CELL CARCINOMA
  4. 0227 - PHASE I/II
  5. 0229 - NEOADJ TX LA NSCLC
  6. 0232 - PROSTATE: BRACHYTHERAPY +/- EXT. BEAM RT
  7. 0235 - NSCLC PET STAGING AND ASSESSMENT (ACRIN 6668)
  8. 0244 - HEAD & NECK: SALIVARY GLAND TRANSFER
  9. 0320 - BRAIN METS: WBRT, SRS VS. WBRT, SRS W/WO TEMODAR, ERLOTINIB
  10. 0415 - PHASE III RANDOMIZED HYOFRACTIONATION VS RT IN LOCALIZED PROSTATE CANCER
  11. 0417 - Phase II CERVIX/BEVACIZUMAB
  12. 0418 - IMRT FOR POSTOP ENDOMETRIAL/CERVIX
  13. 0424 - PHASE II BRAIN
  14. 0436 - PHASE III ESOPHAGUS
  15. 0438 - EXTRACRANIAL 3DCRT UNRESECTABLE LIVER METASTASES
  16. 0513 - GBM:RS, MOTEXAFIN GADOLINIUM + TEMOZOLOMIDE
  17. 0514 - HEAD AND NECK TISSUE BANK
  18. 0517 - PALLIATION BONE METS
  19. 0518 - PROSTATE: OSTEOPOROSIS RISK
  20. 0521 - PROSTATE:CONFORMAL RT PLUS ANDROGEN ABLATION/HIGH RISK
  21. 0522 - ADVANCED UNRESECTED H & N
  22. 0524 - BLADDER CANCER: SURGERY+PACLITAXEL, TRASTUZUMAB, AND RT
  23. 0525 - GBM: RT/TMZ + CONVENTIONAL TMZ VS RT/TMZ + DOSE-INTENSIVE TMZ
  24. 0526 - PHASE II PROSTATE/BRACHY
  25. 0534 - PHASE III PROSTATE
  26. 0611 - URINARY VEGF & MMP LEVELS POST-RT IN PTS WITH GBM
  27. 0612 - PROSTATE DNA MICROARRAY
  28. 0615 - PHASE II NASOPHARYNGEAL
  29. 0617 - PHASE III NSCLC Radiotherapy
  30. 0621 - Phase II Prostate Radiotherapy
  31. 0622 - Phase II Prostate Samarium
  32. 0623 - PHASE II SCLC
  33. 0625/ACRIN6677 - PHASE II GMB
  34. 0627 - PHASE II GBM
  35. 0630 - PHASE II SARCOMA
  36. 0822 - PHASE II RECTAL